Analystreport

PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $47.00 price target on the stock.

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com